Dr Reddy’s receives Form 483 with 7 observations after USFDA inspection at Hyderabad facility
The Hyderabad-based drug major, Dr Reddy’s Laboratories Ltd, on Thursday (June 25) said the United States Food & Drug Administration (USFDA) has completed a Pre-License Inspection (PLI) at its biologics manufacturing facility in Bachupally, Hyderabad. The inspection, conducted between June 16 and June 25, 2026, resulted in the issuance of a Form 483 with seven…
